BR112022005449A2 - Compostos antibacterianos - Google Patents
Compostos antibacterianosInfo
- Publication number
- BR112022005449A2 BR112022005449A2 BR112022005449A BR112022005449A BR112022005449A2 BR 112022005449 A2 BR112022005449 A2 BR 112022005449A2 BR 112022005449 A BR112022005449 A BR 112022005449A BR 112022005449 A BR112022005449 A BR 112022005449A BR 112022005449 A2 BR112022005449 A2 BR 112022005449A2
- Authority
- BR
- Brazil
- Prior art keywords
- antibacterial compounds
- compounds
- antibacterial
- tuberculosis
- medicaments
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
compostos antibacterianos. a presente invenção refere-se aos seguintes compostos em que as partes inteiras são como definidas na descrição e em que os compostos podem ser úteis como medicamentos, por exemplo, para uso no tratamento de tuberculose (por exemplo, em combinação).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19200377 | 2019-09-30 | ||
| PCT/EP2020/077175 WO2021063915A1 (en) | 2019-09-30 | 2020-09-29 | Antibacterial compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022005449A2 true BR112022005449A2 (pt) | 2022-06-21 |
Family
ID=68104409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022005449A BR112022005449A2 (pt) | 2019-09-30 | 2020-09-29 | Compostos antibacterianos |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220372033A1 (pt) |
| EP (1) | EP4038069A1 (pt) |
| JP (1) | JP2022551823A (pt) |
| KR (1) | KR20220075335A (pt) |
| CN (1) | CN114466848A (pt) |
| AU (1) | AU2020360560A1 (pt) |
| BR (1) | BR112022005449A2 (pt) |
| CA (1) | CA3151712A1 (pt) |
| MX (1) | MX2022003816A (pt) |
| WO (1) | WO2021063915A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4296674A1 (en) | 2022-06-20 | 2023-12-27 | Université Toulouse III - Paul Sabatier | Innovative molecules decreasing virulence of mycobacterium for the treatment of tuberculosis |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2301544T1 (sl) | 2002-07-25 | 2013-01-31 | Janssen Pharmaceutica, N.V. | Derivati kinolina kot vmesne spojine za mikobakterijske inhibitorje |
| MX345762B (es) * | 2010-03-18 | 2017-02-15 | Pasteur Institut Korea | Compuestos antiinfecciosos. |
| GB201020076D0 (en) * | 2010-11-26 | 2011-01-12 | Liverpool School Tropical Medicine | Antimalarial compounds |
| CN105745208A (zh) * | 2013-08-02 | 2016-07-06 | 韩国巴斯德研究所 | 一种抗感染化合物 |
| EA201890204A1 (ru) | 2015-07-02 | 2018-06-29 | Янссен Сайенсиз Айрлэнд Юси | Антибактериальные соединения |
| GB201522232D0 (en) * | 2015-12-16 | 2016-01-27 | Liverpool School Tropical Medicine | Combination product |
| MA45377A (fr) | 2016-06-16 | 2019-04-24 | Janssen Sciences Ireland Unlimited Co | Composés hétérocycliques en tant qu'agents antibacteriens |
| JP2019518050A (ja) | 2016-06-16 | 2019-06-27 | ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー | 抗菌薬としての複素環式化合物 |
| WO2018084809A1 (en) * | 2016-11-02 | 2018-05-11 | Nanyang Technological University | Methods for the treatment or prevention of mycobacterial infections |
-
2020
- 2020-09-29 JP JP2022519801A patent/JP2022551823A/ja active Pending
- 2020-09-29 WO PCT/EP2020/077175 patent/WO2021063915A1/en unknown
- 2020-09-29 KR KR1020227010440A patent/KR20220075335A/ko unknown
- 2020-09-29 BR BR112022005449A patent/BR112022005449A2/pt unknown
- 2020-09-29 US US17/764,760 patent/US20220372033A1/en active Pending
- 2020-09-29 CN CN202080068248.5A patent/CN114466848A/zh active Pending
- 2020-09-29 EP EP20789483.3A patent/EP4038069A1/en active Pending
- 2020-09-29 CA CA3151712A patent/CA3151712A1/en active Pending
- 2020-09-29 MX MX2022003816A patent/MX2022003816A/es unknown
- 2020-09-29 AU AU2020360560A patent/AU2020360560A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2020360560A1 (en) | 2022-03-10 |
| EP4038069A1 (en) | 2022-08-10 |
| JP2022551823A (ja) | 2022-12-14 |
| CA3151712A1 (en) | 2021-04-08 |
| WO2021063915A1 (en) | 2021-04-08 |
| CN114466848A (zh) | 2022-05-10 |
| MX2022003816A (es) | 2022-05-06 |
| US20220372033A1 (en) | 2022-11-24 |
| KR20220075335A (ko) | 2022-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112017028318A2 (pt) | compostos antibacterianos | |
| BR112018076126A2 (pt) | compostos heterocíclicos como antibacterianos | |
| BR112018075939A2 (pt) | compostos heterocíclicos como antibacterianos | |
| BR112017027414A2 (pt) | Derivados hidroxiéster, processo para prepará- los e composições farmacêuticas os contendo | |
| CO2017011851A2 (es) | Compuestos novedosos | |
| BR112022003799A2 (pt) | Compostos antibacterianos | |
| BR112018070161A2 (pt) | moduladores de receptores de estrogênio | |
| BR112018014536A2 (pt) | derivados de amônio, um processo para sua preparação e composições farmacêuticas contendo os mesmos | |
| UY38428A (es) | Nuevos compuestos antihelmínticos | |
| CL2015001864A1 (es) | Compuestos derivados de espiropirido[1,2-a]pirazina sustituidos, como inhibidores de la integrasa del vih; composicion farmaceutica que los comprende; y su uso para la profilaxis o el tratamiento de una infeccion por vih. | |
| BR112018075433A2 (pt) | derivados de piperidinila, processo para sua preparação e composições farmacêuticas contendo-os | |
| BR112016017261A8 (pt) | composto, composição farmacêutica, uso de um composto e processo para a fabricação de um composto | |
| BR112018068532A2 (pt) | combinações de inibidores de lsd1 para o tratamento de malignidades hematológicas | |
| UY35276A (es) | Nuevos compuestos que inhiben la actividad de Lp-PLA2 | |
| CR20170425A (es) | Nuevas proteínas específicas para pioverdina y pioquelina | |
| SV2018005760A (es) | Derivados de aminotiazol utiles como agentes antiviricos | |
| CL2011002675A1 (es) | Uso de compuestos derivados de nitrato o sulfato de 9-purin-9-il-3,4-dihidroxitetrahidrofuran-2-il-metilo para reducir la presion intraocular ; composicion farmaceutica oftalmica que comprende los compuestos; y formulacion oftalmica de uso topico que los comprende. | |
| BR112020006710A2 (pt) | Enantiômeros de tiazóis substituídos como compostos antivirais | |
| BR112017009629A2 (pt) | triazolo [4,5-d] pirimidinas como agonistas do receptor canabinoide 2 | |
| BR112018014590A2 (pt) | formulações/composições compreendendo um inibidor de btk | |
| BR112016002638A2 (pt) | novos aza-oxo-indóis para o tratamento e profilaxia de infecção pelo virus sincicial respiratório | |
| CO2022000481A2 (es) | Inhibidores de enzimas | |
| BR112023018655A2 (pt) | Compostos antibacterianos | |
| BR112017015116A2 (pt) | derivados de (r)-2-metil-piperazina como moduladores do receptor cxcr3 | |
| BR112023018654A2 (pt) | Compostos antibacterianos |